Clinical Trial Update: Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation

View source ↗

Summary

A completed clinical trial update examining exacerbations and real-world outcomes in chronic obstructive pulmonary disease patients after a severe exacerbation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED